DB17958InvestigationalGene Therapies
SRP-9005 is a rAAVrh74 vector containing a codon-optimized human SGCG transgene. Developed by the Kurt+Peter Foundation and Sarepta Therapeutics, it is being investigated for the treatment of Limb-girdle muscular dystrophy...
- Code names
- SRP-9005
What you can answer from here — as of August 01, 2025
Which companies are running trials of SRP-9005, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account